Monthly Archives: November 2013

FDA Tells 23andMe to Stop Marketing: Death Knell for DTC Genomics 1.0?

The FDA on Friday published a letter  addressed to 23andMe’s CEO, Anne Wojcicki, telling the company to cease marketing it’s Saliva Collection Kit and Personal Genome Service (PGS). In the letter, Alberto Gutierrez, Director of the Office of In vitro … Continue reading






Posted in DTC Genetic Testing, genomics, personalized medicine, Uncategorized | Tagged , , , , , | Comments Off on FDA Tells 23andMe to Stop Marketing: Death Knell for DTC Genomics 1.0?